drugset / Trial / NCT05165550
Study of Single Ascending Doses of Elsulfavirine to Evaluate the Safety, Tolerability, and Pharmacokinetics of Elsulfavirine and Its Active Metabolite VM-1500A in Healthy Subjects
RandomizedSequentialTriple-blindTreatment
Summary
To assess the safety and tolerability of Elsulfavirine following administration of single oral ascending doses in HIV-negative, healthy subjects.
Timeline
- Start
- 2022-04-12
- Primary completion
- 2022-07-13
- Completion
- 2022-07-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Elsulfavirine | Small molecule | 20 mg | Oral |
| Subject | Elsulfavirine | Small molecule | 40 mg | Oral |
| Subject | Elsulfavirine | Small molecule | 80 mg | Oral |